期刊文献+

支气管扩张患者急性感染的病原菌分布与药敏分析 被引量:27

Distribution and drug sensitivity of pathogens of acute infections in patients with bronchiectasis
原文传递
导出
摘要 目的观察和分析支气管扩张急性感染的病原菌分布及耐药性,进一步提高对临床表现的认识与及时处理。方法选择医院2012年1月-2013年1月500例支气管扩张急性感染住院患者为研对象,采用Microscan AntoSCAN-4微生物鉴定仪器或药敏试验配套装置进行药物敏感性测定,对细菌培养后痰标本的病原菌分布以及药敏试验结果进行分析。结果 500例痰标本中分离出200株病原菌,检出率为40.0%,其中有175株为革兰阴性杆菌占87.5%,25株为革兰阳性球菌占12.5%;总数排在前6位的分别有铜绿假单胞菌37株、鲁氏不动杆菌31株、肺炎克雷伯菌18株、肠杆菌属12株、鲍氏不动杆菌10株、金黄色葡萄球菌9株;铜绿假单胞菌对阿米卡星、亚胺培南、头孢吡肟、哌拉西林以及环丙沙星表现出的耐药性较高,均>90.0%,鲍氏不动杆菌的耐药率普遍较低,金黄色葡萄球菌只对利奈唑胺、亚胺培南和万古霉素敏感率达到100.0%。结论以铜绿假单胞菌为主的革兰阴性菌是支气管扩张急性感染患者的主要病原菌,抗菌药物的合理选用可以有效减少耐药菌的产生。 OBJECTIVE To observe and analyze the distributions and drug resistance of pathogens of acute infection in patients with bronchiectasis,and further improve the understanding of clinical manifestations and timely treatment.METHODS A total of 500inpatients with bronchiectasis who had acute infections from Jan.2012to Jan. 2013were taken as the study subjects.The drug susceptibility test was performed with the Microscan AntoSCAN-4or the susceptibility test device.The distribution of pathogens after sputum sample culture and the susceptibility test result were analyzed.RESULTS A total of 200pathogens were isolated from 500sputum samples,with the detection rate of 40.0%,of which there were 175gram-negative bacilli(87.5%),25gram-positive coccid(12.5%).The top six in total amount were Pseudomonas aeruginosa(37strains),Acinetobacter lwoffii(31strains),Klebsiella pneumoniae(18strains),Enterobacter(12strains),Acinetobacter baumannii(10 strains),Staphylococcus aureus(9strains).Pseudomonas aeruginosa had high resistance of>90%to amikacin, imipenem,cefepime,piperacillin and ciprofloxacin.The resistance of A.baumannii was generally lower.S.aureus was only resistant to linezolid,imipenem and vancomycin,with the resistance rate of 100%.CONCLUSION Gram-negative bacteria,mainly P.aeruginosa,are the main pathogen of acute infection in bronchiectasis patients, rational use of antimicrobial drugs can effectively reduce the occurrence of drug-resistant bacteria.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第9期2130-2132,共3页 Chinese Journal of Nosocomiology
基金 浙江省医药卫生科技基金项目(2013KYA004)
关键词 支气管扩张 急性感染 细菌学特点 Bronchiectasis Acute infection Bacteriological characteristics
  • 相关文献

参考文献10

  • 1李熙霞,程德云,罗玉明,杨丽青,卢琪,徐俐.78例支气管扩张症急性加重患者临床分析[J].临床肺科杂志,2011,16(3):365-366. 被引量:17
  • 2American Thoracic Society Documents. Guidelines for the Manage- ment of Adults with Hospital-acquired, Ventilator-associated, and Healthcare associated Pneumonia[J]. Am J Respir Crit Care Med, 2009,173(1) :131-133.
  • 3邹兰科.支气管扩张症急性感染期81例分析[J].中外健康文摘,2013,6(1):61-62.
  • 4Alekshun MN, LevySB. Bacterial drug resistance : responseto- survival threats. In:StorzG,Hengge-AronisR,editors. Bacte- rialstress responses[J]. Washington DC: ASMPress, 2010,12 (1) :323-366.
  • 5肖中,池峰.支气管扩张症感染患者急性加重期病原菌分布及耐药性分析[J].中华医院感染学杂志,2013,23(12):3020-3022. 被引量:34
  • 6N,Beecroft GM,Cochrane HJ, Milburn. Effect of sex of fetus on asthma during pregnancy: blind prospective study[J]. BMJ,2009,317(7162) :856-857.
  • 7Leroy O,Jaffre S,d'Eserivan T,et al. Hospital-Acquired Pneumoni-a: Risk Factors For Aatimicrohial-Resistant CausativePatho- gens in Critically Ⅲ Patients[J]. Chest, 2008,123 (6): 2034- 2042.
  • 8乔燕伟,刘军,赵学群,杨文杰.老年支气管扩张患者急性加重期的病原菌分布及耐药性分析[J].中国综合临床,2013,29(4):389-391. 被引量:7
  • 9Yuan-Ti Lee,Shiuan-Chih Chen, Kuei-Chuan Chan,et al. Im- pact of infectious etiology on theouteome of Taiwan Residents pa- tients hospitalized with eommunityaequired pneumonia[J]. J Infect Dev Ctries,2013,7(2) :116-124.
  • 10OeDonnell AE,Barker AF, Howite JS,et al. Treatment of id- iophthiie bronchieetasis with aerosolized recombinant human dnasel Chest, 2009,113(5): 1329-13341.

二级参考文献21

  • 1张永祥,杨秀芬,孙武装,王丽红.支气管扩张症的诊治进展[J].国际呼吸杂志,2006,26(9):717-720. 被引量:35
  • 2周庆涛,姚婉贞,陈亚红,沈宁,伍蕊,刘振英.慢性呼吸道疾病并发社区获得性下呼吸道感染住院患者的病原菌调查[J].中国呼吸与危重监护杂志,2007,6(2):82-87. 被引量:18
  • 3谭春婷,贺正一,刘颖,辛小燕,丁秀勇.支气管扩张症50例与慢性鼻窦炎的相关性分析[J].中国实用内科杂志,2007,27(13):1043-1044. 被引量:4
  • 4Barker AF.Brochiectasis[J].N Engl J Med,2002; 346:1383 -1393.
  • 5Angrill J,Agusti C,De celis R,et al.Bacterial inflammation and col-onization in patients with clinically stable brochiectasis[J].Am J Respir Crit Care Med,2001,164(9):1628 -1632.
  • 6Pasteur MC,Helliwell SM,Houghton SJ,et al..An investigation into causative factors in patients with bronchiectasis[J].Am J Respir Crit Care Med,2000,162(4):1277 -1284.
  • 7朱元玉,陈文彬,主编.呼吸病学[M].北京:人民卫生出版社,2004;892-900.
  • 8Ooi GC,Khong PL,Chan -yeung M,et al.High resolution ct quan-tification of bronchiectasis:clinical and functional correlation[J].Radiology,2002 ;225:663-672.
  • 9Van der Bruggen-Bogaarts BA,van der Bruggen HM,van Waes PF,Lammers JW.Assessment of bronchiectasis:comparison of HRCT and spiral volumetric CT[J].J Comput Assist Tomogr.19%; 20 (1):15-19.
  • 10O'Donnell AE, Barker AF,llowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group [ J]. Chest, 1998,113 (5) :1329-1334.

共引文献49

同被引文献190

引证文献27

二级引证文献205

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部